Blonder Tongue Laboratories, Inc.
BDRLOTCTechnology
$0.01
+$0.00(+0.34%)
Market Cap$115941
P/E Ratio—
52W High$0.0969
52W Low$0.0015
Blonder Tongue Laboratories, Inc. (BDRL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BDRL · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $11.16M | $13.21M | $18.11M | $15.75M | $16.38M |
| Cost of Revenue | $7.46M | $9.23M | $12.65M | $9.90M | $13.36M |
| Gross Profit | $3.71M | $3.98M | $5.46M | $5.86M | $3.02M |
| Gross Margin %(computed) | 33.18% | 30.11% | 30.16% | 37.18% | 18.43% |
| Operating Expenses | |||||
| R&D Expenses | $1.10M | $1.26M | $1.78M | $2.59M | $2.52M |
| G&A Expenses | $2.00M | $2.63M | $3.82M | $3.77M | $5.15M |
| Total Operating Expenses | $4.39M | $5.24M | $7.59M | $8.82M | $10.13M |
| Operating Income | ($0.68M) | ($1.26M) | ($2.13M) | ($2.96M) | $1.92M |
| Operating Margin %(computed) | -6.11% | -9.52% | -11.76% | -18.79% | 11.70% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.84M | $0.87M | $0.79M | $0.51M | $0.34M |
| Income Before Tax | ($1.24M) | ($2.10M) | ($2.92M) | $0.10M | $3.02M |
| Income Tax Expense | $0.01M | $0.01M | $0.00M | $0.01M | $0.01M |
| Net Income | ($1.25M) | ($2.12M) | ($3.71M) | $0.08M | $3.00M |
| Net Margin %(computed) | -11.18% | -16.02% | -20.47% | 0.53% | 18.33% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.09 | $-0.15 | $-0.28 | $0.01 | $0.30 |
| Wtd Avg Shares | 14.44M | 13.99M | 13.28M | 12.15M | 9.90M |
| EBITDA | $0.45M | ($0.41M) | ($1.24M) | $1.75M | ($6.01M) |
| EBITDA Margin %(computed) | 4.00% | -3.11% | -6.85% | 11.13% | -36.71% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Blonder Tongue Laboratories, Inc. data
About Blonder Tongue Laboratories, Inc. (BDRL) Income Statement
Blonder Tongue Laboratories, Inc. (BDRL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, BDRL reported revenue of $0.01B, gross profit of $0.00B (gross margin 33.18%), and net income of ($0.00B) — a net profit margin of -11.18%.
Frequently asked questions
BDRL · 4 questionsBlonder Tongue Laboratories, Inc. (BDRL) reported revenue of $0.01B for 2024, down 15.5% year-over-year.
BDRL revenueBDRL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09